Results 201 to 210 of about 146,132 (264)
Disease classification criteria and response criteria are important tools in the conduct of observational studies and clinical trials for rheumatic diseases. This paper updates methodologic guidance for classification and response criteria funded, developed and/or endorsed by the American College of Rheumatology (ACR), incorporating contemporary ...
Sindhu R. Johnson +4 more
wiley +1 more source
What Drives Public Preference for Rare Drugs Coverage in China? Insights From a Multi-Center Discrete Choice Experiment. [PDF]
Wu Y +6 more
europepmc +1 more source
Objective Hydroxychloroquine (HCQ) nonadherence in systemic lupus erythematosus (SLE) stemming from decision complexities can be improved with shared decision‐making (SDM) tools clarifying benefits and harms. This study aimed to develop and evaluate HCQ‐SAFE, a pictogram‐based SDM tool during SLE visits.
Caroline Packee +8 more
wiley +1 more source
Policy lessons regarding medical security for rare diseases inChina: Insights from Zhejiang Province through the multiplestreams framework. [PDF]
Wang M, Rong C, Wang P.
europepmc +1 more source
Access to care during COVID-19: A qualitative study of healthcare system resilience in San Antonio, Texas. [PDF]
Ovuegbe S +4 more
europepmc +1 more source
Patterns of CDSS adoption in primary care: a cluster analysis and predictive modelling study from a stepped wedge trial. [PDF]
Basten J +5 more
europepmc +1 more source
Modeling Financial Insolvency and Income Loss Insurance in Head and Neck Cancer. [PDF]
Araujo AV, Bartho MJ, Low GMI, Li RJ.
europepmc +1 more source
Concerns Regarding the Design, Methodology, and Potential Biases in the Türkiye Heart Failure (TURK-HF) Registry. [PDF]
Zorlu Ç.
europepmc +1 more source

